News

September 11, 2007 - Terumo Interventional Systems announces the launch of its breakthrough Runthrough NS Coronary ...

Home September 10, 2007
Home
Feature | Peter Fail, M.D.

More than ever before, cardiologists are adopting CT as the new standard for cardiac care. In the last five years, CT’s popularity as a diagnostic tool has exploded. Its ability to produce slices as thin as 0.5 mm creates a platform for evaluating patients, detecting disease at early stages and designing treatment roadmaps.

Home September 10, 2007
Home
Feature | Melissa Allen

New York’s Mount Sinai Heart has it all: a star-studded line-up of internationally renowned physicians, scientists and educators, cutting-edge research and unparalleled clinical services. Their secret to success — an integrated approach to cardiovascular healthcare that makes it all possible.

Home September 10, 2007
Home
News

September 11, 2007 - CellCyte Genetics Corp. has entered into a collaborative research agreement with physician scientists at the Cleveland Clinic Foundation to investigate the presence and regulation of heart receptors involved in stem cell trafficking in normal and diseased human hearts, using CellCyte's proprietary compounds, with the goal of increasing volumes of stem cells delivered.

Home September 10, 2007
Home
Feature | Melissa Meyer

CT scanners have evolved over the years and are showing to have applications in the emergent and non-emergent evaluation of underlying cardiovascular issues. The general acceptance for cardiovascular evaluation by CT is limited due to ongoing studies.

Home September 10, 2007
Home
News

September 11, 2007 - Stereotaxis Inc. said more than 10,000 procedures have been performed using the Stereotaxis system, which utilizes advanced, magnet-guided navigational technology intended to help electrophysiologists and cardiologists treat complex arrhythmias and safely perform other interventional procedures.

Home September 10, 2007
Home
Feature | Maureen Leahy-Patano

When it comes to diagnosing disease, image is everything. It is difficult to treat what you can’t see. That’s especially true in the cardiac cath lab where cardiologists performing procedures ranging from simple diagnostic tests to more complex interventional maneuvers rely on imaging technology to guide their course.

Home September 10, 2007
Home
News

September 11, 2007 – Improving how healthcare providers follow proven protocols could reduce the risks of subsequent ...

Home September 10, 2007
Home
Feature

Of the 1. 57 million annual hospital admissions in the U.S. for acute coronary syndromes, 1.24 million are due to unstable angina and non-ST-segment elevation myocardial infarction (UA/NSTEMI).

Home September 10, 2007
Home
Feature | Melissa Allen

According to the Centers for Disease Control and Prevention, more than 70 million Americans currently live with ...

Home September 09, 2007
Home
News

September 7, 2007 - Gary Ansel, M.D., Riverside Methodist Hospital, successfully implanted the GORE VIABAHN ...

Home September 09, 2007
Home
News

September 6, 2007 — ProSolv CardioVascular, a FUJIFILM company (ProSolv), announced at the 12th Annual Scientific ...

Home September 09, 2007
Home
Feature

iffering approaches for the treatment of coronary bifurcation and ostial lesions (CBOL) continue to feed the debate over which stent designs and stenting techniques are most effective.

Home September 09, 2007
Home
News

September 10, 2007 - Signalife launched the sales of its new, FDA-approved, ambulatory 12-lead ECG cardiovascular ...

Home September 09, 2007
Home
Feature | Cristen C. Bolan

Just when drug-eluting stents (DES) were going to revolutionize interventional cardiology, new reports that DES may be associated with increased risk of late-stent thrombosis have many physicians putting the brakes on DES use. Despite this significant bump in the road, stent manufacturers are forging ahead with clinical trials on novel systems and on plans to roll out new DES platforms in 2008.

Home September 09, 2007
Home
Subscribe Now